Fluofarma’s automated cell biology platform brings high throughput to in vitro predictive toxicity testing.
High Content Analysis enables a full "health check" on cells and characterization of a compound's overall in vitro toxicity via a number of specific measurements. Fluofarma has developed a comprehensive panel of cellular assays that enable the assessment of cellular health.
Fluofarma offers predictive in vitro toxicity services including:
If you need to have further details on our in vitro toxicity services, do not hesitate to contact us.
FOCUS: Anticancer drugs profiling
Fluofarma has developed DCffer® method, a powerful approach to
compare and profile your anti-cancer drugs. Read
more [+]